Skip to main content
. Author manuscript; available in PMC: 2016 Oct 27.
Published in final edited form as: Anesthesiology. 2016 Jun;124(6):1265–1276. doi: 10.1097/ALN.0000000000001108

Table 3.

Agreement between Survey and Automated Chart Review (N = 1,578)

Complication Frequency
Agreement
Survey Negative; Chart Review Negative Survey Negative; Chart Review Positive Survey Positive; Chart Review Negative Survey Positive; Chart Review Positive Positive Agreement (%) Negative Agreement (%) Kappa (95% CI)
Myocardial infarction 1,566 5 6 1 15 > 99 0.15 (−0.12 to 0.42)
Cardiac arrest 1,571 2 5 0 0 > 99 0.00 (0.00 to 0.00)
Congestive heart failure 1,545 10 16 7 35 99 0.34 (0.15 to 0.53)
Arrhythmia 1,461 31 58 28 39 97 0.36 (0.25 to 0.46)
Angina 1,568 2 8 0 0 > 99 0.00 (0.00 to 0.00)
Stroke 1,555 12 5 6 41 99 0.41 (0.18 to 0.64)
Deep venous thrombosis 1,558 0 20 0 0 99
Pulmonary embolism 1,560 10 3 5 43 > 99 0.43 (0.18 to 0.69)
Wound infection 1,526 16 32 4 14 98 0.13 (0.00 to 0.25)
Respiratory arrest 1,571 0 7 0 0 > 99
Respiratory failure 1,556 0 19 3 24 99 0.24 (0.02 to 0.46)
Pneumonia 1,531 26 11 10 35 99 0.34 (0.18 to 0.50)
Kidney failure requiring dialysis 1,561 1 13 3 30 > 99 0.30 (0.04 to 0.56)
Nerve injury 1,478 62 36 2 4 97 0.01 (−0.04 to 0.06)
Gastrointestinal bleed 1,546 22 8 2 12 99 0.11 (−0.04 to 0.26)
Peptic ulcer 1,571 0 7 0 0 > 99
Severe pain > 1 day 1,387 3 187 1 1 94 0.01 (−0.01 to 0.02)
Severe nausea/vomiting > 1 day 1,365 150 35 28 23 94 0.18 (0.11 to 0.26)

Kappa is undefined if either the survey or the chart review identifies zero cases of a particular complication.